KLRK1 and breast carcinoma: To test whether increased expression of NKG2D ligands observed on breast carcinoma cells after treatment with docetaxel enhances trastuzumab-mediated cell cytotoxity, tumor cells were analyzed in 51Cr-release assays using human PBMCs from healthy donors as effector cells.